Modulation of non‐adrenergic, non‐cholinergic neural bronchoconstriction in guinea‐pig airways via GABAB‐receptors
Open Access
- 1 August 1989
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 97 (4), 1225-1231
- https://doi.org/10.1111/j.1476-5381.1989.tb12582.x
Abstract
1 Evidence suggests that γ-aminobutyric acid (GABA) and its receptors are present in the peripheral nervous system. We have now investigated the effect of GABA and related substances on non-adrenergic, non-cholinergic (NANC) neurally-evoked bronchoconstriction in the anaesthetised guinea-pig. 2 Bilateral vagal stimulation (5 V, 5 ms, 3 or 5 Hz) for 30 s, after propranolol (1 mg kg−1 i.v.) and atropine (1 mg kg−1 i.v.) evoked a NANC bronchoconstrictor response manifest as a mean tracheal pressure rise of 21.9 ± 1.04 cmH2O (n = 70). The bronchoconstrictor response was reproducible for any given animal. 3 GABA (10 μg-10 mg kg−1 i.v.) did not alter basal tracheal pressure but reduced the NANC bronchoconstrictor response to vagal stimulation in a dose-dependent manner (ED50 = 186 μg kg−1 with a maximal inhibition of 74 ± 3.4% at 10 mg kg−1). Neither the opioid antagonist naloxone (1 mg kg−1 i.v.) nor the α-adrenoceptor antagonist phentolamine (2.5 mg kg−1 i.v.) had any significant effect on the inhibitory response produced by GABA (500 μg kg−1). 4 GABA-induced inhibition was not antagonised by the GABAA-antagonist bicuculline (2 mg kg−1 i.v.). 5 The GABAB-agonist baclofen (10 μg-3 mg kg−1 i.v.) caused a dose-dependent inhibition of the NANC response (ED50 = 100 μg kg−1 with a maximal inhibition of 35.5 ± 2.8% at 3 mg kg−1). The GABAA-agonist, 4,5,6,7-tetrahydroisoxazolo[5,4-C] pyridin-3-ol (THIP), also inhibited the NANC bronchoconstrictor response. However, the dose of THIP required for this effect was high (3 mg kg−1) and the effect (< 10% inhibition) was small. 6 Substance P (SP; 5 μg kg−1 or 25 μg kg−1), produced a bronchoconstrictor response equivalent to that produced by NANC vagal stimulation. This response was significantly increased by injection of GABA. Baclofen had no significant effect on responses evoked by exogenous SP. 7 We conclude that GABA inhibits the release of transmitter from NANC nerves via an action at GABAB receptors and that GABA might play a role in the regulation of neurogenic responses in the airways.This publication has 21 references indexed in Scilit:
- μ-opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airwaysEuropean Journal of Pharmacology, 1987
- Phaclofen: a peripheral and central baclofen antagonistBrain Research, 1987
- THE POSTGANGLIONIC EXCITATORY INNERVATION OF THE MOUSE URINARY BLADDER AND ITS MODULATION BY PREJUNCTIONAL GABAB RECEPTORSJournal of Autonomic Pharmacology, 1986
- ASTHMA AS AN AXON REFLEXThe Lancet, 1986
- γ-aminobutyric acid in peripheral tissuesLife Sciences, 1985
- Local and remote effects of intra-caudate administration of GABA-related drugs on met-enkephalin release in the basal ganglionBrain Research, 1985
- Inhibition of the Excitatory Non‐adrenergic, Non‐cholinergic Neurotransmission in the Guinea Pig Tracheo‐bronehial Tree Mediated by α2‐AdrenoceptorsActa Pharmacologica et Toxicologica, 1984
- Baclofen: stereoselective inhibition of excitant amino acid releaseJournal of Pharmacy and Pharmacology, 1980
- GABA may be a neurotransmitter in the vertebrate peripheral nervous systemNature, 1979
- Versuchsanordnung zu Untersuchungen an der BronchiàlmuskulaturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1940